1. Home
  2. PROV vs CALC Comparison

PROV vs CALC Comparison

Compare PROV & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$15.82

Market Cap

103.0M

Sector

Finance

ML Signal

N/A

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$5.40

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
CALC
Founded
1956
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.0M
88.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PROV
CALC
Price
$15.82
$5.40
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$16.25
$16.00
AVG Volume (30 Days)
7.2K
96.2K
Earning Date
01-27-2026
11-12-2025
Dividend Yield
3.50%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$39,823,000.00
N/A
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$17.82
N/A
Revenue Growth
0.07
N/A
52 Week Low
$12.98
$1.42
52 Week High
$16.36
$7.20

Technical Indicators

Market Signals
Indicator
PROV
CALC
Relative Strength Index (RSI) 54.16 50.30
Support Level $15.55 $5.05
Resistance Level $16.31 $5.71
Average True Range (ATR) 0.28 0.70
MACD -0.03 -0.16
Stochastic Oscillator 63.29 16.74

Price Performance

Historical Comparison
PROV
CALC

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: